Condition

Atypical Teratoid Rhabdoid Tumor (2)

Chordoma (1)

Epithelioid Sarcoma (1)

INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors (1)

Malignant Rhabdoid Tumor (1)

Malignant Rhabdoid Tumor (MRT) (1)

Rhabdoid Tumor of the Kidney (RTK) (1)

SMARCA4-deficient Primary CNS Malignant Tumors (1)

Overall Status

Recruiting (2)

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

St. Jude Children's Research Hospital (1)

Susan Chi, MD (1)

Collaborator

Bristol-Myers Squibb (1)

Epizyme, Inc. (1)

Millennium Pharmaceuticals, Inc. (1)

Takeda Pharmaceuticals U.S.A., Inc. (1)

Study Documents

Intervention Type

drug (2)

procedure (1)

radiation (1)

Funder Type

Other (2)

Study Type

Interventional (2)

atypical teratoid rhabdoid tumor

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant

Recruiting

Atypical Teratoid Rhabdoid Tumor
+6 more

Tazemetostat
+2 more

Boston, Massachusetts
+1 more

Jan 23, 2023

Malignant Rhabdoid Tumor, Atypical Teratoid Rhabdoid Tumor Trial in United States (drug, procedure, radiation)

Recruiting

Malignant Rhabdoid Tumor
Atypical Teratoid Rhabdoid Tumor

alisertib
+9 more

Los Angeles, California
+10 more

Aug 1, 2022